UnitedHealth Group Incorporated
NYSE:UNHMedical - Healthcare Plans
+$3.69 today
- Market cap
- $313.53B
- Beta
- 0.65
- P/E (TTM)
- 30.5
- EPS (TTM)
- $13.24
- Dividend yield
- 2.22%
Volume 17.34M
Average 8.23M
UNH Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
UnitedHealth Group IncorporatedNYSE: UNH
Net Receivables · Q3 FY2026 · quarter ended Sep 2026
Net receivables falls 62.9% from a year ago
Net receivables stood at $20.54B at the end of Q3 FY2026, down 62.9% from a year earlier and down 55.6% from the prior quarter. Over 3 fiscal years it compounded at +20.1% a year.
Context
- Net receivables amounted to 6.6% of total assets at the end of Q3 FY2026, down 11.0 pp from a year earlier.
- Net receivables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -62.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 52.72B USD
- Year-over-year change
- +8.8%
- 4-year CAGR
- +17.1%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 52.72B | +8.8% |
| FY2024 | 2024-12-31 | 48.45B | +24.3% |
| FY2023 | 2023-12-31 | 38.97B | +28.0% |
| FY2022 | 2022-12-31 | 30.45B | +8.4% |
| FY2021 | 2021-12-31 | 28.08B | — |
Net Receivables vs competitors
How UNH compares with its peers on the latest reported figures
- UNH's Sep 2026 net receivables of $20.54B is the 4th highest of the 9 companies compared; the peer median is $10.72B.
- Its year-over-year change of -62.9% is the lowest of 9, against a peer median of -0.8%.
- Net receivables amounts to 6.6% of total assets for UNH, versus a peer median of 19.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $40.31B | -0.8% | +13.4% | 15.9% | |
| Sep 2026 | $31.49B | -0.7% | +19.2% | 20.0% | |
| Sep 2026 | $24.57B | +67.7% | +9.1% | 19.2% | |
| Sep 2026 | $20.54B | -62.9% | +20.1% | 6.6% | |
| Jun 2026 | $18.08B | -16.1% | +10.9% | 21.8% | |
| Sep 2026 | $3.36B | -4.4% | +15.3% | 21.5% | |
| Sep 2026 | $2.87B | +6.7% | +25.0% | 5.0% | |
| Jun 2026 | $380.06M | -49.0% | -27.5% | 3.4% | |
| Mar 2026 | $277.68M | +29.7% | +39.7% | 22.0% | |
| Peer median (excluding UNH) | $10.72B | -0.8% | +14.4% | 19.6% | |
Competitors are the stored peer set for UNH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 21.38B | 23.37B | 25.43B | 25.31B | 24.37B |
| Short-term Investments | 2.53B | 4.55B | 4.2B | 3.8B | 3.76B |
| Net Receivables | 28.08B | 30.45B | 38.97B | 48.45B | 52.72B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.45B | 10.71B | 9.84B | 8.21B | 9.75B |
| Total Current Assets | 61.76B | 69.07B | 78.44B | 85.78B | 90.58B |
| Property, Plant & Equipment (Net) | 8.97B | 10.13B | 11.45B | 10.55B | 10.76B |
| Goodwill | 75.8B | 93.35B | 103.73B | 106.73B | 110.5B |
| Intangible Assets | 10.04B | 14.4B | 15.19B | 23.27B | 20.47B |
| Long-term Investments | 43.11B | 43.73B | 47.61B | 52.35B | 54.25B |
| Tax Assets | (94.81B) | 2.77B | 0 | 0 | 0 |
| Other Non-current Assets | 107.33B | 12.26B | 17.3B | 19.59B | 23.01B |
| Total Non-current Assets | 150.45B | 176.64B | 195.28B | 212.5B | 219B |
| Total Assets | 212.21B | 245.71B | 273.72B | 298.28B | 309.58B |
| Account Payables | 49.13B | 56.77B | 31.96B | 68.56B | 77.37B |
| Short-term Debt | 3.62B | 3.11B | 5.31B | 4.55B | 6.07B |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 2.57B | 3.08B | 3.36B | 3.32B | 3.41B |
| Other Current Liabilities | 22.98B | 26.28B | 58.43B | 27.35B | 28.05B |
| Total Current Liabilities | 78.29B | 89.24B | 99.05B | 103.77B | 114.9B |
| Long-term Debt | 42.38B | 54.51B | 58.26B | 72.36B | 72.32B |
| Deferred Tax Liabilities | 3.27B | 2.77B | 3.02B | 3.62B | 2.42B |
| Deferred Revenue (Non-current) | (3.27B) | 0 | 3.36B | 0 | 0 |
| Other Non-current Liabilities | 15.05B | 12.84B | 11.94B | 15.94B | 18.25B |
| Total Non-current Liabilities | 57.44B | 70.12B | 80.44B | 91.92B | 92.99B |
| Total Liabilities | 135.73B | 159.36B | 174.8B | 195.69B | 207.88B |
| Common Stock | 10M | 9M | 9M | 9M | 9M |
| Retained Earnings | 77.13B | 86.16B | 95.77B | 96.04B | 95.6B |
| Accumulated OCI | (5.38B) | (8.39B) | (7.03B) | (3.39B) | (2.06B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 4.72B | 8.58B | 10.16B | 9.93B | 7.59B |
| Total Equity | 76.48B | 86.35B | 98.92B | 102.59B | 101.7B |
| Total Debt | 46B | 57.62B | 67.44B | 76.9B | 78.39B |
| Net Debt | 24.63B | 34.26B | 42.01B | 51.59B | 54.02B |
UnitedHealth Group Incorporated
NYSE:UNH
Intrinsic Alpha fair value
Locked
Current Price
$349.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.